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Inoculation of immunocompetent lymphoid cells into aUogeneic or semisyngeneic 
Ft recipient mice can lead to graft vs. host (GvH) 1 reactions (1-3).  In the induction 
phase of the GvH the injected lymphocytes recognize and respond to foreign alloan- 
tigens expressed by recipient cells (4). Such recognition can result in the generation of 
a cytotoxic effector T  lymphocyte (CTL) response against the host cells that may be 
associated with  the characteristic symptoms of GvH  disease  (4-6).  Other facets of 
GvH reactivity are the production of autoantibodies and the development of severe 
immunoincompetence (7). It has also been shown that the injection of parental spleen 
cells  into  unirradiated  F1  hybrid  mice  results  in  reduction  or  abrogation  of the 
capability to generate a  cytotoxic T  cell response in vitro (8). This lack of immune 
responsiveness could be accounted for by at least two possible suppressive mechanisms: 
(a) activation of parent-anti-F1 allogeneic CTL; and (b)  activation of a noncytotoxic 
Ft suppressor population resulting from parent-anti-F1 recognition (9). 
Earlier  reports  indicated  that  GvH  reactivity as  detected  by splenomegaly and 
mortality could be prevented or reduced by injecting F1 mice with alloantisera (10, 
11)i In  the  present  study we  have attempted  to protect  F1  hybrid mice from  the 
induction of GvH-associated suppression of the CTL response by injecting Fl  mice 
with alloantibodies before inoculation of parental spleen cells. The results described 
here indicate that alloantiserum directed against either parental haplotype of the F1 
as well as certain monoclonal antibodies against  H-2 or Ia antigens of the F~ host 
prevented  the  induction of GvH-associated CTL suppression.  Moreover,  adoptive 
transfer studies showed that such protection is due to a radiosensitive Ft regulatory T 
cell population, which is activated by specific alloantibodies. 
Materials and Methods 
Mice.  Male  mice,  8-12  wk  of age,  were  used  throughout  these  studies.  All  mice  used 
[(C57BL/10 x  B10.A)F1  [(B10 ×  BI0.A)F1], (C57B1/10 ×  B10.BR)F1  [(B10 ×  BR)F,)], B10.A, 
and B10.BR  (BR)] were obtained from The Jackson Laboratory,  Bar Harbor, Maine. 
Antibodies.  The  alloantisera  used  in  these  experiments  are  described  in  Table  I.  The 
* Supported in part by the Deutsche Forschungsgemeinschaft. 
l Abbreviations used m  this paper: CTL, cytotoxic  T  lymphocytes;  Gvl-t,  graft  vs.  host;  HBSS,  Hanks' 
balanced  salt  solution;  MHC,  major  histocompatibility  complex;  NMS,  normal  mouse  serum;  PBS, 
phosphate-buffered saline. 
1922  Journal of Experimental Medicine . Volume 1154, December 1981  1922-1934 U.  HURTENBACH,  D.  H.  SACHS, AND G.  M.  SHEARER  1923 
monoclonal antibodies were used  in ascites fluid form. The characteristics  of the monoclonal 
reagents have been described in detail elsewhere (12). Some of their properties are summarized 
in Table II. 
Injection of FI Hybrid Mice with Antibodies and Parental Spleen Cells.  The titers of alloantisera 
and  monoclonal reagents were adjusted  to the same concentration  of cytotoxic antibodies by 
diluting with  phosphate-buffered  saline  (PBS).  The reagents were injected  intravenously via 
the tail vein into normal  FI recipients in a  volume of 0.1  ml or 0.5  ml. 24 h  later,  half of the 
mice  from each  group  were injected  intravenously with  parental  spleen cells suspended  in  a 
volume of 0.5 ml in Hanks' balanced salt solution (HBSS)  (8). 
Treatment with a-Thy-l.2 Antibodies Plus Complement.  T  cells were eliminated by incubation of 
100 ×  10  n spleen cells in  1 ml monoclonal anti-Thy-1.2 reagent (New England Nuclear, Boston, 
Mass.)  (dilution  1:100)  for 30 min at  37°C.  After washing the cells in HBSS once, the spleen 
cells were then  incubated  with selected rabbit  complement  for 30  min  at  37°C.  The treated 
cells were washed twice and readjusted to the desired cell concentration. 
In  Vitro Generation of and Assay for Cell-mediated Lympholysis.  The potential  of the treated  Fx 
hybrid  mice to  generate cytotoxic T  cells in  vitro was  tested  8-14  d  after inoculation  of the 
parental  spleen  cells.  In  most  cases,  spleen cells from  two  mice per group  were pooled. The 
responding cells were sensitized a~ainst 2,000-rad  irradiated allogeneic stimulators for 5 d. The 
effector cells were tested in a 4-h  ICr release assay on concanavalin A-stimulated splenic blasts. 
These conditions for sensitization and  assay have been described previously (13).  The percent 
lysis is expressed above medium  control.  Standard  errors of the mean were usually <3%  and 
have been excluded from the graphs for simplicity. 
Results 
Abrogation  of Parental Spleen  Cell Induced  Immunosuppression  by Specific  Alloantisera.  In 
an attempt  to protect FI mice from parental-induced  GvH-associated immunosuppres- 
sion  (8),  (B 10 ×  B 10.A)Fa animals were injected with anti-H-2 a serum before inocula- 
tion  with  B10.A  parental  spleen  cells.  24  h  later  half of the  mice  injected  with  the 
antibodies were inoculated with  15 X  10  n B10.A spleen cells. After a  period of 8  d, the 
immune  potential  of injected  F1  mice was  tested.  F~  lymphocytes were stimulated  in 
vitro  against  BR  allogeneic  spleen  cells,  and  their  cytotoxic  T  cell  activity  was 
determined  5  d  later. 
TABLE  1 
Properties of the Alloantisera Used 
Product  Antiserum  Immunization  Titer  Target cells  number 
1366  Anti-H-2  a  B 10-anti-B 10.A  1:64  B 10.A spleen cells 
1364  Anti-H-2  b  B 10.A-anti-B 10  1:32  B l0 spleen cells 
979  Anti-H-2Kd-Ia  d  (B 10xA/J)Fr  l: 129  B 10.D2 spleen cells 
anti-B 10.D2  <1:2  B 10.A spleen ceils 
TABLE  II 
Properties of the Monoclonal Reagents (Ascites) 
Product 
Code  number  Specificity  Titer  Target cells 
16-1-11N  5164  Anti-K  k  1:2,000  C3H spleen cells 
14-4-4S  5601  Anti-l-E  k  1:32,000  C3H spleen cells 
15-5-5S  5210  Anti-D  k  1:4,000  C3H spleen ceils 
34-2-12S*  5888  Anti-D  d  1:32,000  B 10.A spleen  cells 
* Ozato, K., D. H. Sachs, and N. Mayer. Manuscript in preparation. 1924  PROTECTION  AGAINST  GRAFT  VS.  HOST  BY  ANTISERA 
The data of Fig.  1 show the allogeneic CTL response of (B10 X B10.A)FI spleen 
cells from mice treated with 0.1 ml anti-H-2  a alloantiserum (cytotoxic titer 1:64), and 
subsequently inoculated with B10.A parental spleen cells.  The cytotoxic activity of 
the  effectors from  the  antiserum-treated  mice  was  compared  with  the  response of 
untreated  Fz  animals  or of mice  injected with  normal  mouse serum  (NMS).  The 
results indicate that pretreatment of the F1 mice with anti-H-2  ~ alloantiserum before 
inoculation of the parental lymphocytes resulted in an allogeneic cytotoxic response 
(Fig.  1 F) almost equivalent to that of normal mice (Fig.  1 A). In contrast, the CTL 
potential  of spleen  cells  from F1  mice  that  received no antiserum  or NMS  before 
injection with the same number of NMS parental spleen cells was strongly suppressed 
(Fig.  1 B, D). 
Since the anti-H-2  a antiserum could have acted on host cells, donor cells, or both, 
it was  important  to determine whether antiserum  that  is specific for the host  only 
would  protect against  GvH-induced suppression.  Therefore, the effect of anti-H-2  b 
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FIG,  I,  Cell-mediated cytotoxicity of (BI0  X  B10.A)FI  spleen cells from Fj  mice that  were  (,at) 
untreated, or injected with  (B)  15 x  106 BI0.A spleen ceils;  (C)  0.1  ml NMS i.v.;  (D)  NMS and 
after 24 h  with BI0,A spleen cells intravenously; (E)  0.1  ml anti-H-2  a serum; (F)  anti-H-2  a serum 
and after 24 h with BI0.A spleen cells intravenously; (G)  0.1  ml anti-H-2  h serum; or (H) anti-H-2  s 
serum and after 24 h with B10.A spleen cells. Effector cells were generated by in vitro sensitization 
against BR spleen cells, 8 d post inoculation of B10.A spleen cells. (C)) Effectors stimulated in vitro 
against  BR spleen cells and  tested on  BR  blasts;  (0)  effectors cultured without stimulators and 
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alloantiserum on parental spleen cell-induced suppression was tested. (B 10 × B 10.A) FI 
mice were treated  according to  the protocol described above.  Fig.  1 H  shows that 
suppression  of the  allogeneic CTL  response was  likewise reduced  if F1  mice were 
injected with 0.1 ml of anti-H-2  b alloantiserum (cytotoxic titer 1:32) before inoculation 
of the  B10.A  parental  spleen  cells.  Thus,  these  data  indicate  that  alloantibodies 
directed  against  either  parental  haplotype of the  Fx  reduced  parental  spleen  cell 
induced immunosuppression. 
One possible explanation for the reduction of immunosuppression in the antibody- 
treated mice could be that circulating alloantibodies in the F~ host were absorbed by 
the injected B10.A spleen cells and that the parental lymphocytes were eliminated. 
Therefore, the serum of Fx mice was assayed 24 h after injection of 0.1 ml of undiluted 
antiserum for complement-dependent cytotoxicity. Table III shows that serum from 
F1 mice previously treated with anti-H-2  a or anti-H-2  b alloantiserum did not exhibit 
any detectable cytotoxicity on the specific target cells. In contrast, serum from B 10 or 
B 10.A mice injected with the same amount of nonspecific alloantiserum still contained 
circulating antibodies with cytotoxic activity when tested 24 h later. 
Specificity of the  antibodies was  tested by injecting alloantiserum  that  did  not 
recognize antigens expressed by either parental haplotype in the FI. As demonstrated 
in  Fig.  2,  pretreatment of (B10  ×  B10.A)F1  mice with an  irrelevant alloantiserum 
(anti-H-2Kd-Ia  d) before the injection of B10.A parental spleen cells had no effect on 
the suppression of the allogeneic CTL response (Fig.  2 F). These data indicate that 
specific antibodies against either haplotype of the F1 strain, but not antibodies specific 
for antigens not expressed by the F1 host, are capable of reducing the parental spleen 
cell-induced immunosuppression. 
To determine the amount of alloantibodies required to abrogate B10.A parental 
spleen cell-induced suppression in the (B 10 ×  B 10.A) F1 recipients, mice were injected 
TABLE  III 
Complement-dependent Cytotoxicity of Serum from Mice Injected with O. 1 ml 
Alloantiserum  24 h Previously 
Percent trypan blue positive cells 
B 10 targets*  B 10.A targets:l: 
Serum/dilutions  1:2  1:4  1:2  1:4 
Normal (BI0 ×  BI0.A)F1  14  18  17  15 
F~ injected with NMS  17  13  15  15 
9  12  24  16 
F1 injected with anti-H-2  a  14  10  16  15 
8  10  15  18 
FI injected with anti-H-2  b  11  15  20  17 
14  13  14  21 
Anti-H-2"  11  14  >80  >80 
Anti-H-2  h  72  >80  13  19 
BI0 injected with anti-H-2"  11  6  >80  >80 
13  1  >80  46 
BI0.A injected with anti-H-2  h  46  21  9  15 
63  43  7  14 
* Complement control  11%. 
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Fro.  2.  Cell-mediated  cytotoxicity of (B10  ×  BI0.A)F1  spleen cells  from I"~ mice which were (A) 
untreated, or injected with (B)  15 x  l0  s B10.A spleen cells;  (C) 0.1  ml anti-H-2  a serum; (D) anti-H- 
2" serum and  BI0.A spleen cells  24  h  later;  (E)  0.1  ml anti-t/-2Kd-Ia  d serum;  (F)  anti-H-2Kd-Ia  d 
serum and  B10.A  spleen cells  24  h  later.  Effector cells  were generated  8  d  after  injection  of the 
B10.A spleen cells and assayed as described in legend of Fig. 1. 
with various dilutions of anti-H-2  a alloantiserum. The undiluted antiserum (cytotoxic 
titer  1:64) was diluted in PBS to  1:4 or  1:8, and 0.1  ml of each dilution was injected 
intravenously, followed by 15 ×  106 B 10.A spleen cells 24 h later. 8 d post-inoculation 
of the parental cells, the F1 lymphocytes were sensitized in vitro against allogeneic BR 
stimulators. The results shown in Fig. 3 demonstrate that CTL suppression could be 
abrogated using a  1:4 dilution of the anti-H-2  a alloantiserum  diluted  to a  cytotoxic 
titer  of  1:16  (Fig.  3 C).  The  data  thus  suggest  that  low amounts  of alloantibodies 
provide protection from parental spleen cell-induced suppression. However, treatment 
with a further twofold dilution of the antiserum to 1:8 had no effect on the induction 
of CTL suppression in the F1 recipients  (Fig.  3 D). 
Treatment  of  the  F1  Mice  with  Monoclonal Antibodies against  H-2  Subregion  Deter- 
minants.  In an attempt to map the protective effect of the specific alloantisera,  (B10 
X B 10.A)F1 mice were injected with monoclonal antibodies against different H-2 and 
Ia determinants. The various monoclonal reagents were adjusted to the same titer (1: 
25)  and  0.5  ml  of the  diluted  reagents  was injected  into each  of the  F1  mice  24 h 
before the  injection of 15  ×  106 B10.A spleen  cells,  The potential  for generation of 
alloreactive  CTL  in  vitro  was  tested  8  d  later.  The  data,  summarized  in  Fig.  4, 
demonstrate  that  monoclonal reagents  binding to K k antigens  (Fig.  4 B)  or to I-E  k 
antigens  (Fig.  4 C)  completely abrogated B10.A spleen  cell-induced suppression.  In 
contrast, a monoclonal reagent binding to D k antigens, an irrelevant antibody for the 
B 10.A strain  (Fig.  4 D), was ineffective. 
Using the same monoclonal reagents,  the effect of GvH-associated immune sup- 
pression was also tested in the (B 10 ×  BR)FI strain. The protocol for injection of the U.  HURTENBACH,  D.  H.  SACHS,  AND  G.  M.  SHEARER  1927 
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FIG.  3.  Cell-mediated cytotoxicity of (BI0  X BI0.A)FI effector cells to BR alloantigen. Injection 
of FI mice with various dilutions of anti-H-2  a alloantiserum. F] mice were:  (A)  (O)  untreated, (0) 
injected  with  15  ×  106  B10.A  spleen  cells;  (B)  (O)  injected  with  0.1  ml  undiluted  anti-H-2  a 
alloantiserum, (0) undiluted anti-H-2  a serum plus  15 ×  100 BI0.A spleen cells 24 h  later; (C)  (O) 
injected with 0.1  ml anti-H-2  a serum,  1:4 diluted, (0)  anti-H'2a serum  1:4 diluted plus  15  ×  l0  s 
Bt0.A spleen 24 h later; (D) (O) injected with 0.1  ml anti-H-2  = serum 1:8 diluted, (0) injected with 
anti-H-2  A serum  1:8 diluted plus  15 ×  l0  s B10.A spleen cells 24 h  later. 8 d  after injection of the 
BI0.A spleen cells effector cells were generated and assayed as described in legend of Fig.  1. Solid 
lines indicate effectors stimulated  against  BR spleen cells and  tested on  BR  blasts;  broken  lines 
indicate effectors cultured without stimulators and tested on BR blasts. 
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FIG.  4.  Cell mediated cytotoxicity of spleen cells from (BI0 X BI0.A)FI mice injected with 0.5 ml 
of diluted monoclonal antibodies (cytotoxic titer adjusted to  1:25) to BR alloantigen. Spleen cells 
derived from Fz mice which were (A)  (O)  untreated, or injected with:  (S)  15 X  10  s BI0.A spleen 
cells; (B) (O) monoclonal anti-K  k, (O) anti-K  k and BI0.A spleen cells 24 h later; (C)  (O) monoclonal 
anti-I-E  k, (0) anti  -I-Ek and BI0.A spleen cells; (D)  (O) monoclonal anti-D  k, (0) anti  -Dk and BI0.A 
spleen cells. 8 d  post-inoculation of B10.A spleen cells effector cells were generated and assayed as 
described in legend of Fig.  1.  Solid lines indicate effectors stimulated against BR spleen cells and 
tested on BR blasts; broken lines indicate effectors cultivated without stimulators and tested on BR 
blasts. 1928  PROTECTION  AGAINST  GRAFT  VS.  HOST  BY  ANTISERA 
antibodies was  identical to that  used above. 9  d  after inoculation of 20  X  10  s BR 
parental spleen cells the generation of cytotoxic T  cells against B 10.A alloantigen was 
tested in vivo. Results similar to those observed in the (B10 X  B10.A)Fx strain were 
obtained  in  the  (B10  X  BR)Fa  mice,  when  treated  with  the  anti-K  k or  anti-I-E  k 
monocional reagents (Fig. 5). In addition, injection of monoclonal antibodies against 
D k antigens  prior to  inoculation of BR parental  spleen cells also  diminished  CTL 
immune suppression  (Fig. 5 D). It should be noted that this anti-D  k reagent did not 
protect  (B10  X  B10.A)F1  mice  from  suppression  (Fig.  4 E),  which  illustrates  the 
specificity of these reagents in protecting against CTL suppression. Monoclonal anti- 
D d antibodies, which are not reactive with either Fa haplotype in the (B10 X BR)F1, 
provided no protection from suppression (Fig. 5 E), although this reagent did protect 
against  parental suppression  in the  (B10 X  B10.A)F1  (data not shown). These data 
indicate that specific antibodies directed against H-2 determinants of either haplotype 
protect the Fa recipients against  parental spleen cell induced suppression.  However, 
this protective effect may not necessarily be limited only to anti-MHC antibodies. 
Activation  of F1  Regulatory Cells by  Anti-H-2 a  Antiserum.  Among  several  possible 
explanations, protection against GvH-associated immunosuppression could be due to 
a  regulatory process that  involves the stimulation  of a  lymphoid cell population.  If 
antibodies activate such regulatory cells, it should be possible to protect Fx mice by 
syngeneic lymphocytes adoptively transferred from alloantibody-treated animals. To 
test  this,  (B10  X  B10.A)F1  mice were  inoculated  with  40  X  106 spleen  cells  from 
syngeneic F1 donor mice injected with 0.1 ml anti-H-2  a alloantiserum 24 h previously. 
The same recipients were also inoculated intravenously with 10 X  106 B10.A parental 
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Fro.  5.  Cell mediated cytotoxicity of spleen cells from (BI0 ×  BR)FI mice injected with 0.5 ml of 
diluted monoclonal antibodies to BI0.A alloantigen. Spleen cells derived from F1 mice which were 
(A)  (O)  untreated, or injected with (9t) 20 X  106 BR spleen cells; (B)  (O) monoclonal anti-Kk; (O) 
anti-K  k and BR spleen cells 24 h  later;  (C)  ((:3) monoclonal anti-IE  k, (0) anti -I-Ek plus BR spleen 
cells 24 h  later;  (D)  (O)  monoclonal anti-D  k, (0)  anti -Dk plus BR spleen cells 24 h  later;  (E)  (O) 
monoclonal anti-D  d, (0)  anti -D° plus BR spleen cells 24 h  later. 9  d  post-inoculation of the BR 
spleen cells the effector cells were generated by in vitro sensitization against BI0.A stimulators and 
assayed on BI0.A  blasts. Solid lines indicate effectors stimulated against  BI0.A spleen cells and 
tested on B 10.A blasts; broken lines indicate effectors cultivated without stimulators and tested on 
B10.A blasts. U.  ttURTENBACH,  D.  H.  SACHS,  AND  G.  M.  StlEARER  1929 
spleen cells, which would normally be suppressive. The potential to generate a CTL 
response  against  BR  alloantigen  was  tested  9  d  later.  Fig.  6C  shows  that  the 
alloreactivity of spleen cells from these mice was comparable to the response of the 
untreated controls  (Fig.  6A).  In contrast,  adoptive transfer of F1 spleen cells  from 
untreated F~ donor mice, as shown in Fig. 6 D, did not protect against CTL suppression 
(Fig. 6 B). Thus, these data demonstrate that a  regulatory cell population in the Fa 
host  is activated by the alloantibodies that  protect from GvH-associated CTL sup- 
pression. 
To partially characterize this regulatory cell population, similar adoptive transfer 
studies were performed with irradiated or T  cell-depleted spleen cells from syngeneic 
F1 mice. These F1 spleen cell donor mice were injected with 0.5 ml diluted monoclonal 
anti-K  k antibodies 24 h  before adoptive transfer. Thus,  (B10 X  B10.A)Fa recipients 
were inoculated with 50 ×  l0  G Fa spleen cells (from antibody-treated donors) either 
treated with anti-Thy-l.2 plus complement or irradiated with 2,000 rad in addition 
to 10 X  106 B10.A parental lymphocytes. 8 d  later the CTL potential of spleen cells 
from these recipients was compared with mice inoculated with untreated F~ spleen 
cells from anti-K  k injected donors. As shown in Fig. 7, the protective effect of anti-K  k- 
activated Fl cells was completely eliminated after T  cell depletion or irradiation with 
2,000 rad. Thus, the anti-H-2-activated F~ cells that counteract CTL suppression are 
radiosensitive T  lymphocytes. 
Discussion 
Previous studies have shown that unirradiated F~ hybrid mice injected with parental 
spleen cells develop some characteristics of GvH reactivity associated with nonspecific 
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FIc.  6.  Cell-mediated  cytotoxicity  of  (B10  X  B10.A)FI  spleen  cells  to  BR  alloantigen.  The 
responder cells derived from Fv mice which were (A) untreated, or injected with (B)  10 x  10  s BL0.A 
spleen cells, (C)  10 X 106 BtO.A spleen cells plus 40 ×  l0  s Fl spleen cells adoptively transferred from 
donor mice treated with 0.[ ml anti-H-2  a alloantiserum 24 h previously, (D)  10 X  106 B10.A spleen 
cells  plus 40  X  106 Ft  spleen cells adoptively transferred from untreated donor mice.  Effector cells 
were generated 9 d post inoculation of the parental and Fj cells and assayed as described in legend 
of Fig.  I. Solid fines indicate effectors stimulated against BR spleen cells and tested on BR blasts; 
broken lines  indicate effectors cultured without stimulation and tested on BR blasts. 1930  PROTECTION AGAINST GRAFT VS.  HOST BY ANTISERA 
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F~G.  7.  Cell-mediated  cytotoxicity  of  (B10 X  BR)FI  spleen cells to  B10.A alloantigen.  The 
responder cells derived from Fl mice which were (C)) untreated, or inoculated with: (0) 20 x  108 BR 
spleen cells; (El) 20 ×  106 BR spleen cells plus 50 ×  106 Fl spleen cells adoptively transferred from 
donor mice injected with monoclonal anti-Kk; (A) 20 X 106 BR spleen cells plus 50 ×  106 anti-Thy- 
1.2 and complement-treated  FI spleen cells from anti-K  k injected donors; (A) 20 ×  106 BR spleen 
cells plus 50 ×  106 2,000-rad irradiated  Fl spleen cells from anti-K  k injected donors. Effect0r cells 
were generated  12 d  post-inoculation  of the  parent and  F1 cells and  generated  and assayed as 
described in legend of Fig. 5. Lysis of B 10.A blasts by effectors cultured without stimulators was in 
all groups <5% and therefore omitted in this graph. 
suppression of the potential  to generate a  CTL response in vitro (8, 9). In the present 
study  we  have  attempted  to  protect  the  F1  recipients  from  CTL  suppression  by 
injecting  mice with  specific alloantibodies  before inoculation  of the  parental  spleen 
cells. The main findings of this study demonstrate  that  (a)  F1 mice can be protected 
from CTL  suppression  by alloantiserum  directed  against  either  parental  haplotype; 
(b) protection  can be achieved equally well with monoclonal  reagents against  H-2K, 
D, or I-E antigens;  (c) protection is only provided by specific antibodies;  (d) low titers 
ofalloantibodies are sufficient to exert protection; and (e) protection can be adoptively 
transferred  by radiosensitive,  Thy-l-positive  spleen  ceils  from syngeneic  donors  pre- 
viously treated with specific alloantiserum. 
It  has  been  previously, reported  that  GvH  disease  can  be  decreased  either  by 
injecting the recipients (10,  11,  14,  15) or by treating the donor cells with antirecipient 
alloantibodies  (16,  17).  However, the mechanism of abrogation  of GvH reactivity as 
assessed in  those studies  by splenomegaly and  mortality  rates is conjectural.  Several 
explanations  could  account  for the  alloantibody-induced  protection  against  immu- 
nosuppression.  The  first, covering of host  major histocompatibility  complex  (MHC) 
determinants  by the  antibodies,  which  prevents  their  recognition  of the  inoculated 
parental  effector  cells,  has  been  suggested  previously  (10).  Such  a  mechanism  can 
only account  for protection  by alloantibodies  directed  against  H-2  determinants  of 
the  F1 strain  that  are foreign  to the  inoculated  parental  cells.  This does not  explain 
protection by alloantibodies specific for the same haplotype of the parental  inoculum, 
unless  steric  hindrance  of the  foreign  allodeterminants  is  considered.  Furthermore, 
the  amount  of antibodies  injected  is probably too small  to saturate  all alloantigenic 
sites in the F1 host. A  second  explanation,  binding of antibodies  to donor MHC  and 
thereby  eliminating  the  relevant  parental  lymphocytes  in  vivo by complement-de- 
pendent  lysis  with  the  injected  alloantibodies,  is  also  unlikely.  No  evidence  of U. HURTENBACH, D. H. SACHS, AND G. M. SHEARER  1931 
circulating  antibodies  was  obtained  24  h  after  serum  injection  which  could  be 
absorbed by the inoculated parental spleen cells. 
Anti-idiotype antibodies have been reported to inhibit GvH proliferation (18) and 
GvH disease (19). Although the presence of anti-idiotype antibodies in the anti-MHC 
alloantisera or in the monoclonal reagents derived from ascites fluid is theoretically 
possible (20),  this explanation seems unlikely, because the protocol for generation of 
anti-idiotypic antibodies is different from that used to raise these alloantibodies (21). 
A more likely possibility is that alloantibodies activate a regulatory cell population 
in  the  F1  host,  probable  because  protection  can  be  adoptively  transferred  into 
syngeneic recipients.  Spleen  cells from mice previously treated with alloantibodies 
provide  protection  from  GvH-associated  suppression  equal  to  that  produced  by 
injection of the recipients with antibodies. Therefore, it appears that such a regulatory 
effect is an active process triggered by antibodies specific for either haplotype expressed 
by the F1 mice. Since antibodies specific for both parents in the (B ×  A)F1 protected 
against suppression induced by parent A, the activation step need not be specific only 
for the haplotype of the parental cells inoculated. The function of this cell population 
in the GvH model seems to be to prevent suppression and perhaps to restore immune 
reactivity following severe GvH-associated immunosuppression. 
GvH-associated  immunosuppression  is  triggered  by the  injected parental  spleen 
cells that recognize and react against the other parental haplotype in the F1 host (3, 
4).  Such A-anti-B immune reactivity in the (B  ×  A)F1 would be recognized by the 
host as anti-self reactivity. In the process of protecting itself against this "autoimmune" 
response,  the entire  immune system would be suppressed,  because GvH-associated 
immunosuppression appears to be nonspecific and affects cell-mediated (8, 9) as well 
as humoral immunity (22).  To counter such drastic suppression, it could be advan- 
tageous to  have a  regulatory cell population capable of restoring normal  immune 
functions. Similar regulatory networks have been reported for antibody (23) and T 
cell responses (24). The latter has been described in Fa rats, which could be protected 
against GvH by pretreatment with suboptimal doses of parental T cells. However, the 
regulatory system in rats is rapidly activated (within 2 d), and it is specific for the 
immunizing parental haplotype. In contrast, the regulatory system described in the 
present  report  is  activated  by antibodies,  which would  probably  require  a  longer 
period if generated in vivo by the injected parental cells. 
The present study indicates that such a  regulatory cell population is activated by 
antibodies against host antigens. In addition, the injection of parental T  cells into F1 
mice  can  result  in  the  production  of autoantibodies,  which  were  reported  to  be 
generated by F1 B cells (25).  This phenomenon is based on the allogeneic effect, in 
which parental T  cells can activate antibody production by F1 B cells (26). Although 
in the present study we have injected alloantibodies specific for F1 MHC antigens, it 
is  possible  that  other  antibodies  against  different  host  cell  surface  antigens,  e.g., 
autoantibodies generated by F~ B cells as a result of the allogeneic effect, could reverse 
GvH-associated  suppressed  T  cell  immunity.  Studies  are  in  progress  to  test  this 
possibility. Thus, the recovery of the suppressed immune function of F1 mice undergo- 
ing a chronic GvH reaction could be due to activation of regulatory T  cells by anti- 
MHC antibodies produced in situ by parental B cells and/or autoantibodies produced 
by  F1  B  cells.  Under  more  natural  conditions  such  regulatory  cells  may be  one 
component  of  a  complex  regulatory  network  composed  of suppressor  cells  and 1932  PROTECTION AGAINST GRAFT VS.  HOST BY ANTISERA 
regulatory cells  activated  by antibodies  against  self-components.  In  this  model,  it 
would be expected that the presence of autoantibodies is paralleled by low suppressor 
cell activity. This, in fact, is the case in the autoimmune NZB/W mouse strains (27). 
Such low suppressor cell activity might be due to the activation of regulatory cells 
(activated by autoantibodies), which serve to counteract the effect of suppressor cells. 
Studies are in progress to characterize the regulatory cells and to analyze the signals 
involved in activation of these regulatory events. A more thorough understanding of 
this system may be useful for treatments of GvH diseases in humans. 
Summary 
Injection  of parental  spleen  cells  into  unirradiated  F1  hybrid  mice  results  in 
suppression of the potential to generate cytotoxic T  lymphocyte (CTL) responses in 
vitro. In an attempt to protect the F1 mice from immunosuppression, the recipients 
were injected with antibodies specific for major histocompatibility complex (MHC)- 
encoded antigens of the Fa mice 24 h  before inoculation of the parental spleen cells. 
8-14 d  later, the generation of CTL responses in vitro against  H-2 alloantigens was 
tested.  Alloantiserum  directed  against  either  parental  haplotype  of the  F~  strain 
markedly  diminished  the  suppression  of CTL  activity.  Furthermore,  monoclonal 
antibodies recognizing H-2 or Ia antigens protected the F1 mice from parental spleen 
cell-induced  suppression.  Although  this  study  has  been  limited  to  reagents  that 
recognize host H-2 determinants, these findings do not necessarily imply that protec- 
tion against  graft vs. host  (GvH) can be achieved only with anti-MHC  antibodies. 
However, protection was observed only by antibodies reactive with F1 antigens, and 
small  amounts  of the  alloantibodies were sufficient  to  diminish  CTL suppression. 
Adoptive  transfer  of spleen  cells  from  syngeneic  F1  mice  treated  with  anti-H-2  a 
alloantiserum  24 h  previously provided protection equal  to that  of injection of the 
recipients with alloantibodies. The cells necessary for this effect were shown to be T 
cells and to be radiosensitive to 2000 rad. This cell population is induced by antisera 
against Ft cell surface antigens and effectively counteracts GvH-associated immuno- 
suppression. 
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